|
Ser-ap-esDrug - Ser-ap-es The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine
Strength -
25MG;15MG;0.1MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
012193
Product Number -
005
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Ser-ap-es
Ser-a-gen 25mg;15mg;0.1mg Tablet; Oral
Ser-ap-es 25mg;15mg;0.1mg Tablet; Oral Hydrap-es 25mg;15mg;0.1mg Tablet; Oral Hydrochlorothiazide W/ Reserpine And Hydralazine 25mg;15mg;0.1mg Tablet; Oral Hydroserpine Plus (r-h-h) 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydrochlorothiazide, And Hydralazine Hcl 25mg;15mg;0.1mg Tablet; Oral NewDrugInformation |